Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17139127 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | December 2020 | July 2023 | Allow | 31 | 2 | 1 | No | No |
| 17135878 | METHODS FOR AMPLIFYING NUCLEIC ACID USING TAG-MEDIATED DISPLACEMENT | December 2020 | July 2023 | Allow | 31 | 1 | 1 | No | No |
| 17122055 | PRIMER, KIT AND METHOD FOR DETECTING TAIHE BLACK CHICKEN EGG | December 2020 | February 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17093298 | MULTIPLEXED OPTIMIZED MISMATCH AMPLIFICATION (MOMA)-CANCER RISK ASSESSMENT WITH NON-CANCER ASSOCIATED TARGETS | November 2020 | December 2023 | Abandon | 37 | 0 | 1 | No | No |
| 17091639 | USING RANDOM PRIMING TO OBTAIN FULL-LENGTH V(D)J INFORMATION FOR IMMUNE REPERTOIRE SEQUENCING | November 2020 | March 2023 | Allow | 28 | 1 | 1 | No | No |
| 17083803 | METHOD FOR PREIMPLANTATION GENETIC SCREENING OF EMBRYOS FOR DETECTION OF STRUCTURAL REARRANGEMENTS | October 2020 | June 2023 | Allow | 32 | 2 | 0 | No | No |
| 17079268 | METHODS FOR 3' OVERHANG REPAIR | October 2020 | June 2022 | Allow | 20 | 0 | 0 | No | No |
| 17078463 | HIGHLY SELECTIVE NUCLEIC ACID AMPLIFICATION PRIMERS | October 2020 | June 2021 | Allow | 8 | 1 | 0 | No | No |
| 16949159 | METHODS AND COMPOSITIONS FOR MULTIPLEX PCR | October 2020 | August 2023 | Allow | 34 | 2 | 1 | No | No |
| 17070707 | Method for Synthesizing Nucleic Acids, in particular Long Nucleic Acids, Use of Said Method and Kit for Implementing Said Method | October 2020 | March 2023 | Allow | 29 | 1 | 0 | No | No |
| 17064508 | METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID SEQUENCING | October 2020 | March 2023 | Allow | 30 | 1 | 0 | No | No |
| 17024225 | METHOD AND DEVICE FOR TESTING TARGET NUCLEIC ACID | September 2020 | April 2023 | Allow | 31 | 1 | 1 | No | No |
| 17019109 | METHODS AND COMPOSITIONS FOR PROTEIN AND PEPTIDE SEQUENCING | September 2020 | April 2023 | Allow | 31 | 1 | 1 | No | No |
| 17014540 | CANCER-RELATED BIOLOGICAL MATERIALS IN MICROVESICLES | September 2020 | May 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17002321 | Method of detecting genetic material in a biological sample and a device for its implementation | August 2020 | January 2023 | Allow | 29 | 1 | 0 | No | No |
| 16990000 | PRIMER SET FOR PCR FOR BACTERIAL DNA AMPLIFICATION, KIT FOR DETECTION AND/OR IDENTIFICATION OF BACTERIAL SPECIES, AND, METHOD OF DETECTION AND/OR IDENTIFICATION OF BACTERIAL SPECIES | August 2020 | December 2023 | Abandon | 40 | 3 | 0 | No | No |
| 16986066 | METHODS AND COMPOSITIONS FOR WHOLE GENOME AMPLIFICATION AND GENOTYPING | August 2020 | October 2022 | Allow | 27 | 1 | 0 | No | No |
| 16983947 | SEQUENCING FROM MULTIPLE PRIMERS TO INCREASE DATA RATE AND DENSITY | August 2020 | June 2022 | Allow | 22 | 0 | 0 | No | No |
| 16945173 | METHODS FOR SEQUENCING WITH SINGLE FREQUENCY DETECTION | July 2020 | October 2022 | Allow | 27 | 1 | 1 | No | No |
| 16934799 | METHOD AND KIT FOR DETERMINING NEUROMUSCULAR DISEASE IN SUBJECT | July 2020 | February 2023 | Abandon | 31 | 0 | 1 | No | No |
| 16917185 | FETAL ANEUPLOIDY DETECTION BY SEQUENCING | June 2020 | January 2023 | Allow | 31 | 2 | 0 | No | No |
| 16908822 | METHODS FOR SCREENING A SUBJECT FOR A CANCER | June 2020 | July 2023 | Allow | 37 | 2 | 1 | Yes | No |
| 16908572 | LEUKEMIA METHYLATION MARKERS AND USES THEREOF | June 2020 | January 2023 | Abandon | 31 | 0 | 1 | No | No |
| 16908567 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | June 2020 | March 2023 | Allow | 33 | 1 | 1 | No | No |
| 16906115 | TM MAPPING METHOD | June 2020 | March 2023 | Allow | 33 | 2 | 0 | No | No |
| 16898897 | BLOOD DNA METHYLATION BIOMARKER DIAGNOSTIC TEST FOR ANXIETY AND DEPRESSIVE DISORDERS | June 2020 | August 2022 | Allow | 26 | 0 | 1 | No | No |
| 16891018 | METHOD FOR PRODUCING RNA | June 2020 | October 2021 | Allow | 17 | 1 | 1 | No | No |
| 16768802 | RAPID NUCLEIC ACIDS SEPARATION AND SAMPLE PREPARATION VIA HOLLOW-CENTERED SILICA MICROSPHERE | June 2020 | July 2022 | Allow | 26 | 2 | 1 | No | No |
| 16768627 | PCR CONTROLS | May 2020 | August 2022 | Allow | 27 | 1 | 0 | No | No |
| 16764642 | METHODS AND KITS FOR USING RECOMBINANT MICROORGANISMS AS DIRECT REAGENTS IN BIOLOGICAL APPLICATIONS | May 2020 | June 2023 | Allow | 37 | 3 | 1 | No | No |
| 15930488 | SAMPLE PREPARATION METHODS, SYSTEMS AND COMPOSITIONS | May 2020 | July 2021 | Allow | 14 | 1 | 1 | Yes | No |
| 16761458 | METHODS AND KITS FOR TARGETED ENRICHMENT OF TARGET DNA WITH HIGH GC CONTENT | May 2020 | April 2022 | Allow | 24 | 1 | 0 | No | No |
| 16864408 | METHODS USING RANDOMER-CONTAINING SYNTHETIC MOLECULES | May 2020 | September 2021 | Allow | 17 | 0 | 0 | No | No |
| 16862637 | Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers | April 2020 | March 2023 | Abandon | 34 | 0 | 1 | No | No |
| 16758873 | Methods for preparing RNA probes for exome sequencing and for depleting organelle DNA | April 2020 | January 2023 | Abandon | 33 | 0 | 1 | No | No |
| 16755829 | NEW TOOLS FOR ASSESSING FIMH BLOCKERS THERAPEUTIC EFFICIENCY | April 2020 | September 2023 | Allow | 41 | 2 | 1 | Yes | No |
| 16755190 | METHOD FOR DIAGNOSING ALZHEIMER DEMENTIA VIA BACTERIAL METAGENOMIC ANALYSIS | April 2020 | September 2023 | Abandon | 42 | 2 | 1 | No | No |
| 16845472 | DIRECT AMPLIFICATION AND DETECTION OF VIRAL AND BACTERIAL PATHOGENS | April 2020 | August 2023 | Allow | 40 | 5 | 2 | No | No |
| 16840168 | ANALYSIS OF Y-CHROMOSOME STR MARKERS | April 2020 | May 2022 | Allow | 25 | 4 | 1 | No | No |
| 16834141 | DEGENERATE OLIGONUCLEOTIDES AND THEIR USES | March 2020 | August 2021 | Abandon | 17 | 1 | 0 | No | No |
| 16651940 | ANALYSIS METHOD FOR EXTRACELLULAR VESICLES, USING SIZE EXCLUSION CHROMATOGRAPHY, AND USE FOR SAME | March 2020 | July 2023 | Allow | 39 | 1 | 1 | No | No |
| 16819992 | DIAGNOSIS OF FETAL ABNORMALITIES USING POLYMORPHISMS INCLUDING SHORT TANDEM REPEATS | March 2020 | February 2022 | Allow | 23 | 1 | 1 | No | No |
| 16816481 | Methods for Microbial DNA Analysis | March 2020 | February 2022 | Allow | 23 | 4 | 1 | No | No |
| 16800450 | DETECTION OF SEQUENCE ELEMENTS IN NUCLEIC ACID MOLECULES | February 2020 | January 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 16795388 | NANOPORE-BASED POLYMER ANALYSIS WITH MUTUALLY-QUENCHING FLUORESCENT LABELS | February 2020 | May 2022 | Abandon | 27 | 2 | 0 | No | Yes |
| 16793680 | COMPOSITIONS AND METHODS FOR LABELING OF AGENTS | February 2020 | August 2022 | Abandon | 30 | 2 | 1 | No | Yes |
| 16790283 | METHODS AND KITS FOR REDUCING ADAPTER-DIMER FORMATION | February 2020 | May 2022 | Abandon | 27 | 3 | 0 | No | No |
| 16785837 | MOLECULAR ASSAY METHODS | February 2020 | January 2021 | Allow | 12 | 0 | 0 | No | No |
| 16786198 | METHOD FOR SELECTING AND AMPLIFYING POLYNUCLEOTIDES | February 2020 | August 2021 | Allow | 18 | 2 | 1 | No | No |
| 16773539 | METHODS AND COMPOSITIONS FOR GENERATING ASYMMETRICALLY-TAGGED NUCLEIC ACID FRAGMENTS | January 2020 | March 2021 | Allow | 14 | 1 | 1 | No | No |
| 16746216 | COMPOSITIONS, METHODS, AND KITS FOR AMPLIFYING NUCLEIC ACIDS | January 2020 | September 2021 | Allow | 20 | 2 | 1 | No | No |
| 16743604 | COMPOSITIONS AND METHODS FOR IDENTIFICATION OF A DUPLICATE SEQUENCING READ | January 2020 | April 2021 | Allow | 15 | 1 | 0 | No | No |
| 16631324 | EML4-ALK GENE MUTATION ANALYSIS METHOD | January 2020 | May 2023 | Allow | 40 | 3 | 1 | Yes | No |
| 16726034 | MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER | December 2019 | December 2021 | Abandon | 24 | 1 | 1 | No | No |
| 16625437 | TARGET-ENRICHED MULTIPLEXED PARALLEL ANALYSIS FOR ASSESSMENT OF FETAL DNA SAMPLES | December 2019 | January 2023 | Allow | 36 | 2 | 0 | Yes | No |
| 16720823 | EFFICIENT METHODS AND COMPOSITIONS FOR MULTIPLEX TARGET AMPLIFICATION PCR | December 2019 | March 2023 | Allow | 39 | 1 | 1 | No | No |
| 16623707 | ASSESSING TRANSPLANT COMPLICATION RISK WITH TOTAL CELL-FREE DNA | December 2019 | March 2023 | Allow | 39 | 2 | 1 | No | No |
| 16622059 | DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES OF LONG NONCODING RNAs FOR PATHOLOGIES AND TOXICITIES INDUCING HEART DISORDERS | December 2019 | December 2022 | Allow | 36 | 2 | 1 | No | No |
| 16619945 | TWO MOLECULAR MARKERS, KITS AND APPLICATIONS FOR GLAUCOMA DIAGNOSIS | December 2019 | June 2023 | Abandon | 42 | 2 | 1 | No | No |
| 16616735 | ARRAY-BASED METHODS FOR ANALYSING MIXED SAMPLES USING DIFFERENTLY LABELLED ALLELE-SPECIFIC PROBES | November 2019 | September 2022 | Allow | 33 | 1 | 1 | No | No |
| 16616741 | ARRAY-BASED METHODS FOR ANALYSING MIXED SAMPLES USING DIFFERENTLY LABELLED ALLELE-SPECIFIC PROBES | November 2019 | April 2022 | Allow | 29 | 1 | 0 | No | No |
| 16616725 | ARRAY-BASED METHODS FOR ANALYSING MIXED SAMPLES USING DIFFERENT ALLELE-SPECIFIC LABELS, IN PARTICULAR FOR DETECTION OF FETAL ANEUPLOIDIES | November 2019 | August 2022 | Allow | 33 | 2 | 0 | No | No |
| 16616532 | OLIGONUCLEOTIDE PRESERVATION METHOD | November 2019 | October 2022 | Allow | 35 | 2 | 0 | No | No |
| 16616134 | SINGLE MOLECULE DETECTION AND QUANTIFICATION OF NUCLEIC ACIDS WITH SINGLE BASE SPECIFICITY | November 2019 | December 2022 | Abandon | 37 | 2 | 0 | No | No |
| 16606944 | METHOD FOR REMOVING NON-TARGET RNA FROM RNA SAMPLE | October 2019 | February 2022 | Allow | 27 | 1 | 0 | No | No |
| 16597877 | Kits and Methods for Detecting Methylated DNA | October 2019 | December 2021 | Abandon | 26 | 2 | 1 | No | No |
| 16577491 | CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA | September 2019 | April 2022 | Allow | 31 | 3 | 1 | No | No |
| 16495721 | PROGRAMMABLE NUCLEIC ACID SYNTHESIS CASCADE | September 2019 | July 2021 | Allow | 22 | 0 | 1 | Yes | No |
| 16494121 | METHOD FOR DETECTING TARGET MOLECULE IN WHICH ROLLING CIRCLE AMPLIFICATION IS USED | September 2019 | March 2022 | Allow | 30 | 1 | 0 | No | No |
| 16570873 | METHOD AND SYSTEM FOR SEQUENCING NUCLEIC ACIDS | September 2019 | July 2021 | Allow | 22 | 2 | 1 | No | No |
| 16564948 | TEST FOR DETECTING ALZHEIMERS DISEASE | September 2019 | March 2022 | Allow | 31 | 1 | 0 | No | No |
| 16481964 | METHODS AND COMPOSITIONS RELATING TO DETECTION OF RECOMBINATION AND REARRANGEMENT EVENTS | July 2019 | September 2023 | Abandon | 50 | 4 | 0 | No | No |
| 16525826 | METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING | July 2019 | January 2023 | Allow | 41 | 1 | 1 | Yes | No |
| 16480535 | COMPOSITIONS AND METHODS FOR DETECTING A MUTANT VARIANT OF A POLYNUCLEOTIDE | July 2019 | September 2022 | Allow | 37 | 2 | 0 | No | No |
| 16518321 | SERIAL FORMATION OF TERNARY COMPLEX SPECIES | July 2019 | May 2022 | Allow | 34 | 2 | 1 | Yes | No |
| 16478705 | METHODS OF RNA AMPLIFICATION | July 2019 | September 2021 | Allow | 26 | 1 | 0 | No | No |
| 16477794 | RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING AND PHYLOGENETIC IDENTIFICATION | July 2019 | March 2022 | Abandon | 32 | 0 | 1 | No | No |
| 16505496 | POLYMERASE-TEMPLATE COMPLEXES | July 2019 | February 2021 | Allow | 19 | 1 | 1 | No | No |
| 16476256 | PCR MEASURING METHOD AND MEASUREMENT DEVICE | July 2019 | September 2023 | Allow | 50 | 5 | 1 | Yes | No |
| 16503262 | METHODS, SYSTEMS, COMPOSITIONS, KITS, APPARATUS AND COMPUTER-READABLE MEDIA FOR MOLECULAR TAGGING | July 2019 | April 2021 | Allow | 21 | 2 | 1 | No | No |
| 16460647 | DETECTION OF NEOPLASIA BY ANALYSIS OF METHYLATED DNA | July 2019 | February 2021 | Allow | 19 | 1 | 1 | Yes | No |
| 16433621 | MULTIPLEXED CATALYZED REPORTER DEPOSITION | June 2019 | January 2023 | Allow | 44 | 1 | 1 | No | No |
| 16464284 | METHOD AND BIOMARKERS FOR IN VITRO DIAGNOSIS OF MENTAL DISORDERS | May 2019 | March 2022 | Abandon | 33 | 1 | 1 | No | No |
| 16422056 | Polyphenolic Additives in Sequencing by Synthesis | May 2019 | March 2021 | Allow | 22 | 1 | 0 | No | No |
| 16417817 | SAFE SEQUENCING SYSTEM | May 2019 | April 2021 | Allow | 23 | 1 | 0 | No | No |
| 16414705 | MULTI-PRIMER AMPLIFICATION METHOD FOR TAGGING OF TARGET NUCLEIC ACIDS | May 2019 | April 2021 | Abandon | 23 | 1 | 0 | No | No |
| 16408302 | METHODS AND COMPOSITIONS FOR GENERATING ASYMMETRICALLY-TAGGED NUCLEIC ACID FRAGMENTS | May 2019 | October 2019 | Allow | 6 | 0 | 0 | Yes | No |
| 16347185 | METHODS FOR ASSESSING RISK USING MISMATCH AMPLIFICATION AND STATISTICAL METHODS | May 2019 | June 2022 | Abandon | 37 | 0 | 1 | No | No |
| 16399941 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | April 2019 | September 2021 | Abandon | 29 | 4 | 1 | No | No |
| 16392114 | METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET NUCLEIC ACIDS | April 2019 | October 2021 | Allow | 30 | 0 | 1 | No | No |
| 16389596 | Computational Method for Detecting Fusion Events | April 2019 | September 2021 | Allow | 29 | 2 | 0 | Yes | No |
| 16389584 | Highly Multiplexed Polymerase Chain Reaction | April 2019 | June 2021 | Abandon | 26 | 1 | 0 | No | No |
| 16389573 | Multiplexed Gene Fusion Detection Method | April 2019 | March 2021 | Abandon | 23 | 1 | 1 | No | No |
| 16389588 | Detection of Fusion Events Using Replicate PCR Reactions | April 2019 | July 2021 | Abandon | 27 | 1 | 0 | No | No |
| 16389565 | Method for Detecting a Genomic Fusion Event | April 2019 | April 2021 | Abandon | 24 | 1 | 0 | No | No |
| 16386729 | SINGLE REACTION MULTIPLEX PCR PRIMER DESIGN FOR AMPLIFYING MULTIPLE HLA CLASS I AND II GENES | April 2019 | December 2022 | Allow | 44 | 3 | 2 | No | No |
| 16342722 | UNIMOLECULAR APTAMER-BASED SENSORS FOR PATHOGEN DETECTION | April 2019 | May 2023 | Allow | 49 | 1 | 1 | No | No |
| 16327754 | METHOD FOR INSERTING DESIRED DNA FRAGMENT INTO SITE LOCATED ADJACENT TO BINDING DOMAIN OF DNA-BINDING PROTEIN | April 2019 | June 2022 | Allow | 39 | 1 | 0 | No | No |
| 16385970 | Methods for Treating and Detecting Johne's Disease in Cattle | April 2019 | November 2021 | Abandon | 31 | 0 | 1 | No | No |
| 16384262 | PRIMERS, COMPOSITIONS, AND METHODS FOR NUCLEIC ACID SEQUENCE VARIATION DETECTION | April 2019 | February 2022 | Allow | 34 | 3 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner STRZELECKA, TERESA E.
With a 13.3% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 13.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner STRZELECKA, TERESA E works in Art Unit 1637 and has examined 1,132 patent applications in our dataset. With an allowance rate of 49.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.
Examiner STRZELECKA, TERESA E's allowance rate of 49.5% places them in the 12% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by STRZELECKA, TERESA E receive 2.20 office actions before reaching final disposition. This places the examiner in the 56% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by STRZELECKA, TERESA E is 38 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +35.8% benefit to allowance rate for applications examined by STRZELECKA, TERESA E. This interview benefit is in the 83% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 18.5% of applications are subsequently allowed. This success rate is in the 20% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 40.3% of cases where such amendments are filed. This entry rate is in the 63% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 90.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 69% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 72.2% of appeals filed. This is in the 60% percentile among all examiners. Of these withdrawals, 87.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 59.7% are granted (fully or in part). This grant rate is in the 61% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 5.7% of allowed cases (in the 88% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 9.6% of allowed cases (in the 89% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.